Mersana Therapeutics Inc (MRSN)
2.12
+0.10
(+4.95%)
USD |
NASDAQ |
Oct 04, 16:00
2.13
+0.01
(+0.47%)
After-Hours: 20:00
Mersana Therapeutics Shareholders Equity (Annual): 36.90M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 36.90M |
| December 31, 2022 | 92.06M |
| December 31, 2021 | 121.74M |
| December 31, 2020 | 228.09M |
| December 31, 2019 | 78.32M |
| Date | Value |
|---|---|
| December 31, 2018 | 8.795M |
| December 31, 2017 | 69.99M |
| December 31, 2016 | -55.62M |
| December 31, 2015 | -42.69M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
36.90M
Minimum
2023
228.09M
Maximum
2020
111.42M
Average
92.06M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Chimerix Inc | 193.03M |
| Marinus Pharmaceuticals Inc | 16.76M |
| Jaguar Health Inc | 4.961M |
| Seres Therapeutics Inc | -44.86M |
| PDS Biotechnology Corp | 26.13M |